PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23398317-6	2013	A significant increase in N-acetylgalactosamine (GalNAc) in terminal position (p = 0.02) observed in some of the IgAN patients, became more pronounced when sialic acid was removed from IgA1, indicating enhanced expression of alpha-2,6-sialyltransferase in patients compared with controls (p < 0.0001).	N-acetylgalactosaminuronic acid	49-55	IGAN1	Homo sapiens	113-117	
23398317-8	2013	IgAN patients with both IgA1 and IgA2 glomerular deposits (21.7%) had increased GalNAc in terminal position (p = 0.003).	N-acetylgalactosaminuronic acid	80-86	IGAN1	Homo sapiens	0-4